WCN23-0349 EFFICACY OF DACLATASVIR AND LOW-DOSE SOFOSBUVIR IN TREATMENT OF HEPATITIS –C VIRUS INFECTION IN PATIENTS OF MAINTANANCE-HEMODIALYSIS- 3 YEARS TRIAL IN A TERTIARY RENAL CENTER

Autor:	JABIN, M. 1, Mostafi, M. 1, Kaiser, A.M. 1, Samir, M.R.K. 1, Linkon-, T.C. 1, Ghosh, H. 1, Juthi, S.M. 1
Zdroj:	In Kidney International Reports March 2023 8(3) Supplement:S287-S288
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu